Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals
Sydney, Australia 11 May 2021 – Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Shaemus Gleason as Executive Vice President U.S. Operations as the company expands its presence, clinical trials, and operations in the U.S. Shaemus joins Clarity from Bayer’s Oncology Strategic…